Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study was to observe the effect of amino acid formula on infants with cow's milk protein allergy; to evaluate the role of food avoidance and Open Food Challenge test in the diagnosis of infants with cow's milk protein allergy; to observe the allergic process in infants with cow's milk protein allergy and to explore the criteria for diagnosis and treatment.


Clinical Trial Description

This is a multi-center, prospective cohort study. This study plans to recruit 200 subjects. The suitable subject will be enrolled and there are seven visits through the 6-month study. Efficacy parameters are the positive incidence of open food challenge test, growth and development index (Weight, Height, Head circumference;), and the improvement of CMPA symptoms (such as SCORAD, gastrointestinal tract, respiratory, comfort scores). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03769051
Study type Observational
Source Peking University Third Hospital
Contact
Status Completed
Phase
Start date June 20, 2015
Completion date April 2019

See also
  Status Clinical Trial Phase
Completed NCT04596059 - The Journey of Children With Cow's Milk Protein Allergy in Mexico.
Not yet recruiting NCT06130085 - Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination N/A
Completed NCT02953223 - A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Completed NCT03085134 - Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides N/A
Recruiting NCT06288503 - Hydrolysed Rice Formula Study N/A
Completed NCT06273371 - Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain